Why should I store my child’s stem cells?

Stem cells have a great potential importance in the future of healthcare. They are capable of repairing and replacing different cell types in the body.

With advancements in technology, it is hoped stem cells will be used in therapy for degenerative diseases and in treatment of damage to tissue.

Storing umbilical cord blood offers peace of mind and the opportunity to avail of these advancements at a later stage.

Cord blood stem cells are among the youngest possible stem cells that can be collected and stored. Exploring their use in treating disease is the subject of many clinical trials.

The first cord blood transplant took place in 1988 and since then more than 40,000 transplants have taken place using cord blood stem cells.

These unique stem cells collected at birth can be used in life-saving treatments for diseases such as inherited blood disorders, like Sickle Cell Disease – there are also clinical trials to explore their use in treating conditions such as cerebral palsy and autism.

There are further trials to using cord blood stem cells in treating type-1 diabetes, autoimmune diseases and for brain repair.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    WideCells Group PLC

    More articles like this

    WideCells Group PLC

    Wonder stem cell cure for heart failure

    MILLIONS of heart failure patients could be saved thanks to a new stem cell therapy being tested in Britain. Researchers yesterday revealed a breakthrough treatment that cuts out the need for operations by revitalising damaged tissue

    WideCells Group PLC

    Cord Blood Stem Cells

    Umbilical cord blood stem cells are currently being used to treat more than 80 diseases and disorders, such as leukaemias and aneamias. What are cord blood stem cells? Stem cells found in cord blood are haemopoietic (blood forming). Haemopoietic stem

    WideCells Group PLC

    Why Widecells?

    What’s more important than your health and that of your family? At WideCells we are leading a transformation in stem cell services and stem cell treatment to give you new and better healthcare options. It’s our

    WideCells Group PLC

    What are stems cells?

    It’s estimated that 1 in 3 of us will need a stem cell transplant in our lifetime. What are stem cells? Stem cells are essential for the normal health and functioning of the body, during both development

    WideCells Group PLC

    YOUR BABYCELLS JOURNEY

    Congratulations! No doubt you’re glowing in your pregnancy. With advice and tips coming from all directions, naturally,  as part of your journey you will be wondering how best to protect your family’s future. Your thoughts With

    WideCells Group PLC

    WideCells Group PLC Get Conviction Buy Stance from Align Research

    WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, has today announced that following the Group’s recent placing, Align Research has released an update note

    WideCells Group PLC

    INTERVIEW: Widecells Group Placing and Looking ahead

    Widecells Group Plc (LON:WDC) CEO João Andrade & CFO David Bridgland talk to DirectorsTalk about the lifting of a trading suspension. João explains why the shares were suspended, if anything was hindered as a result and

    WideCells Group PLC

    Wonder stem cell cure for heart failure

    Millions of heart failure patients could be saved thanks to a new stem cell therapy being tested in Britain. Researchers revealed a breakthrough treatment that cuts out the need for operations by revitalising damaged tissue using

    WideCells Group PLC

    WideCells Group PLC Placing Update and Financial Position

    WideCells Group PLC (LON:WDC) the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, provides the following update on its financial position. As announced on 5 June 2018, the

    WideCells Group PLC

    WideCells Group PLC Audited Preliminary Results

    WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, announced today its audited preliminary results for the period ended 31 December 2017. Copies of the

    WideCells Group PLC

    Why do we have blood types?

    More than a century after their discovery, we still don’t really know what blood types are for. Do they really matter? Carl Zimmer investigates. When my parents informed me that my blood type was A+, I

    WideCells Group PLC

    How synthetic DNA could be used as a sensor

    Konstantinos Vavitsas, The University of Queensland Researchers believe that DNA – the molecule that stores information about life – could one day be used as a type of sensor, to record information based on its surroundings. Synthetic